Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal

BACKGROUND: Resistance to antimicrobial agents of pathogenic bacteria has become a major problem in routine medical practices. Carbapenem resistance has long been increasing. The production of carbapenem- hydrolysing β-lactamases (carbapenamases), which include NDM, KPC, OXA-48, IMP-1 and VIM is the...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Antimicrob Resist Infect Control
Główni autorzy: Sah, Ranjit, Khadka, Shusila, Shrestha, Gentle Sunder, Acharya, Subhash, Aryal, Diptesh, Shrestha, Pramesh, Kattel, Hari Prasad, Shah, Niranjan Prasad, Pokhrel, Bharat Mani, Singh, Yogendra Prasad, Rijal, Basista, Erdem, Hakan
Format: Artigo
Język:Inglês
Wydane: BioMed Central 2019
Hasła przedmiotowe:
Case Report
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6794824/
https://ncbi.nlm.nih.gov/pubmed/31636898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13756-019-0608-1
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy